Relavo to Showcase Innovative Home Dialysis Solution with Keiretsu Forum Sponsorship at ACA Innovation Showcase

Philadelphia, PA – [MAY 1, 2024] – Keiretsu Forum Mid-Atlantic, South-East, and Texas regions are proud to announce their sponsorship of Relavo Medical at the Innovation Funders Showcase during the 2024 Angel Capital Association (ACA) Summit. This partnership highlights Keiretsu Forum's dedication to supporting healthcare innovations that significantly enhance patient care and accessibility.

Transforming Kidney Failure Treatment with the PeritoneX

Founded by a team of female biomedical engineers from Johns Hopkins University, Relavo Medical is revolutionizing the treatment of kidney failure with its groundbreaking device, the PeritoneX. Designed to make home dialysis safer and more accessible, the PeritoneX reduces the risk of infection—a major barrier to the adoption of peritoneal dialysis (PD).

Addressing a Critical Need

Peritoneal dialysis allows patients to manage their treatment from home, significantly reducing the time spent in dialysis clinics. Despite its benefits, only 12% of kidney failure patients currently choose PD due to the high risk of peritonitis, an infection that can result from the treatment process. The PeritoneX addresses this issue by providing an in-line disinfection system that is compatible with existing PD setups, greatly reducing the impact of microbial contamination.

Innovative Features and Recognitions

The PeritoneX has demonstrated the ability to achieve a greater than 4-log reduction in peritonitis-causing bacteria in laboratory settings, representing a significant advancement in patient safety. The device’s compatibility with current PD systems, ease-of-use, and its effectiveness in preventing secondary contamination are pivotal in its design. Recognized for its potential, Relavo Medical was awarded Small Business Innovation Research - Phase I & II awards from the National Science Foundation.

Potential Impact on Healthcare

The broader commercial potential of the PeritoneX is profound, aiming to disrupt renal replacement therapy by increasing safe access to peritoneal dialysis. With over 500,000 kidney failure patients in the United States requiring treatment annually, and only 52,000 receiving PD, the introduction of the PeritoneX could save the healthcare system over $100 million annually in peritonitis-related hospitalizations.

About Relavo Medical

Relavo Medical is focused on enabling people with kidney failure to live better and live longer by making home dialysis safer and more accessible. Through innovative technology and a commitment to patient safety, Relavo Medical strives to increase the adoption of peritoneal dialysis, offering kidney failure patients a higher quality of life.

 

About Keiretsu Forum Mid-Atlantic, South-East, and Texas

Keiretsu Forum is the world’s largest private equity angel investment network, with over 2,000 accredited investors across 34 North American and 23 International chapters. They have invested more than $1 billion in various sectors, including technology, life sciences, and consumer products, over the last 23 years.

 

The ACA Summit, set to take place in Columbus, Ohio from May 13-15, 2024, will serve as a vital platform for networking, innovation, and investment opportunities in the healthcare sector.

 

For more information on the ACA Summit and Relavo Medical's participation, please contact:

Cindi Sutera

AMS Communications

cindis@amscommunications.net

610-613-2773

---